Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Minoxidil measurement |
Component |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Fetal minoxidil syndrome |
Causative agent (attribute) |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
3 |
Minoxidil adverse reaction |
Causative agent (attribute) |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Allergy to minoxidil |
Causative agent (attribute) |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil [androgen alopecia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil 20mg/mL topical liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Minoxidil 50mg/mL topical liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Product containing minoxidil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing minoxidil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing minoxidil in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Product containing precisely minoxidil 50 milligram/1 gram conventional release cutaneous foam (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
|
Allergy to minoxidil |
Causative agent (attribute) |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minoxidil 50 milligram/1 gram conventional release cutaneous foam (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minoxidil 50 milligram/1 gram conventional release cutaneous foam (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing minoxidil in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing only minoxidil in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Product containing only minoxidil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Fetal minoxidil syndrome |
Causative agent (attribute) |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 50 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 50 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 100 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 100 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 20 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |
Minoxidil 20 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minoxidil (substance) |
Inferred relationship |
Some |
1 |